Compounds of the pregnane series with an oxygen function in the 19-position, processes for their manufacture and pharmaceutical preparations containing these compounds
CA 1114367 A · Owner: Novartis Ag · Inventors: Biollaz, Michel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of the pregnane series with an oxygen function in the 19-position, processes for their manufacture and pharmaceutical preparations containing these compounds Abstract of the Disclosure, 19-Oxygenated steroid compounds of the pregnane series of the formula I, (I), in which, R1 represents a hydrogen atom and, R2 represents an .alpha.-oriented lower alkanoylthio group or, R1 and R2 together represent a carbon-carbon bond or an .alpha.or .beta.-oriented methylene radical, R3 represents a free hydroxymethyl group or a hydroxymethyl group etherified by a lower alkyl or esterified by a lower alkanoyl; or represents a formyl group a, carboxyl group or a lower alkoxycarbonyl group and, R4 …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted December 15, 1981. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended December 15, 1998.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.